X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-20 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.67 | +150,000 | 2,780,697 | +6% | +$100,500 | ||||||
2024-01-02 | VNRX | Eight Corp Ltd | 10% | S - Sale | $0.90 | -20,000 | 12,005,332 | 0% | -$18,000 | ||||||
2023-12-15 | VNRX | Eight Corp Ltd | 10% | S - Sale | $0.75 | -20,000 | 12,025,332 | 0% | -$15,000 | ||||||
2023-12-18 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.83 | +10,000 | 278,223 | +4% | +$8,300 | ||||||
2023-12-15 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.77 | +10,000 | 268,223 | +4% | +$7,700 | ||||||
2023-12-13 | VNRX | Rootsaert Rodney Gerard | Secretary | P - Purchase | $0.60 | +10,000 | 1,086,370 | +1% | +$6,000 | ||||||
2023-12-08 | VNRX | Reynolds Cameron John | Pres, CEO | P - Purchase | $0.67 | +10,000 | 2,746,312 | 0% | +$6,700 | ||||||
2023-11-27 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.77 | +20,000 | 2,601,175 | +1% | +$15,400 | ||||||
2023-11-27 | VNRX | Futcher Edward | Dir | P - Purchase | $0.80 | +9,000 | 427,936 | +2% | +$7,200 | ||||||
2023-11-24 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.76 | +10,000 | 2,581,175 | 0% | +$7,600 | ||||||
2023-11-22 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.71 | +20,000 | 2,571,175 | +1% | +$14,200 | ||||||
2023-11-16 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.81 | +10,000 | 258,223 | +4% | +$8,100 | ||||||
2023-08-31 | VNRX | Henshall Mickie | Dir | P - Purchase | $1.25 | +3,706 | 18,706 | +25% | +$4,633 | ||||||
2023-09-05 | VNRX | Barnes Phillip | Dir | P - Purchase | $1.30 | +5,000 | 24,686 | +25% | +$6,500 | ||||||
2023-08-31 | VNRX | Faulkes Martin Charles | Dir | P - Purchase | $1.28 | +9,716 | 2,029,532 | 0% | +$12,436 | ||||||
| M | 2023-08-29 | VNRX | Micallef Jacob Vincent | Chief Scientific Officer | P - Purchase | $1.25 | +20,000 | 328,253 | +6% | +$25,063 | |||||
2023-08-25 | VNRX | Micallef Jacob Vincent | Chief Scientific Officer | P - Purchase | $1.24 | +20,000 | 308,253 | +7% | +$24,800 | ||||||
2023-08-24 | VNRX | Kway Jasmine | CEO - Singapore Volition | P - Purchase | $1.20 | +5,000 | 86,840 | +6% | +$6,000 | ||||||
2023-08-24 | VNRX | Futcher Edward | Dir | P - Purchase | $1.22 | +5,000 | 418,936 | +1% | +$6,100 | ||||||
2023-08-24 | VNRX | Michel Gaetan | COO | P - Purchase | $1.23 | +5,000 | 212,997 | +2% | +$6,150 | ||||||
2023-08-16 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $1.21 | +8,000 | 254,057 | +3% | +$9,680 | ||||||
2023-08-16 | VNRX | Reynolds Cameron John | Pres, CEO | P - Purchase | $1.22 | +10,000 | 2,536,312 | 0% | +$12,200 | ||||||
2023-06-02 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $1.59 | +10,000 | 217,257 | +5% | +$15,900 | ||||||
2023-02-22 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $1.75 | +234,000 | 2,235,418 | +12% | +$409,500 | ||||||
2022-12-19 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.27 | +5,000 | 197,550 | +3% | +$11,350 | ||||||
| M | 2022-12-16 | VNRX | Micallef Jacob Vincent | Chief Scientific Officer | P - Purchase | $2.22 | +32,339 | 261,505 | +14% | +$71,884 | |||||
2022-12-16 | VNRX | Faulkes Martin Charles | Dir | P - Purchase | $2.10 | +55,000 | 1,993,068 | +3% | +$115,500 | ||||||
2022-12-12 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.09 | +4,350 | 192,550 | +2% | +$9,092 | ||||||
2022-12-08 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | P - Purchase | $2.07 | +4,800 | 51,494 | +10% | +$9,936 | ||||||
2022-11-28 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.21 | +5,000 | 188,200 | +3% | +$11,050 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |